Data / Drug companies / MSN Organics Private Limited
MSN Organics Private Limited: 30 products in the FDA NDC directory, labeler code 50379
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
MSN Organics Private Limited (labeler code 50379) lists 30 products in the FDA National Drug Code Directory. By type: 30 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on March 28, 2025.
The request: Watch MSN Organics Private Limited (FDA labeler code 50379): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 50379
- Products in commercial distribution
- 30
- Packages
- 30
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule III 1
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- March 22, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 30 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 30 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 29 | 96.7% |
| Liquid | 1 | 3.3% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Lansoprazole | 50379-0031 | Powder | Bulk ingredients | March 28, 2025 |
| Fosfomycin sodium | 50379-0030 | Powder | Bulk ingredients | September 29, 2024 |
| Belumosudil mesylate | 50379-0028 | Powder | Bulk ingredients | September 28, 2024 |
| Fosfomycin tromethamine | 50379-0029 | Powder | Bulk ingredients | September 26, 2024 |
| Vibegron | 50379-0027 | Powder | Bulk ingredients | September 24, 2024 |
| Tapinarof | 50379-0026 | Powder | Bulk ingredients | August 1, 2023 |
| Trientine tetrahydrochloride | 50379-0025 | Powder | Bulk ingredients | March 30, 2023 |
| Perampanel (3/4 hydrate) | 50379-0024 | Powder | Bulk ingredients | January 29, 2021 |
| Ticagrelor | 50379-0023 | Powder | Bulk ingredients | March 12, 2020 |
| Parecoxib sodium | 50379-0022 | Powder | Bulk ingredients | December 29, 2017 |
| Febuxostat | 50379-0021 | Powder | Bulk ingredients | December 1, 2016 |
| Perampanel | 50379-0020 | Powder | Bulk ingredients | October 3, 2016 |
| Prazosin hydrochloride | 50379-0019 | Powder | Bulk ingredients | February 5, 2016 |
| Atomoxetine hydrochloride | 50379-0018 | Powder | Bulk ingredients | October 12, 2015 |
| Trientine hydrochloride | 50379-0017 | Powder | Bulk ingredients | October 7, 2015 |
| Cinacalcet hydrochloride | 50379-0016 | Powder | Bulk ingredients | September 10, 2015 |
| Clopidogrel bisulfate | 50379-0015 | Powder | Bulk ingredients | May 15, 2015 |
| Rivastigmine | 50379-0014 | Liquid | Bulk ingredients | March 24, 2015 |
| Dimethyl fumarate | 50379-0013 | Powder | Bulk ingredients | January 15, 2015 |
| Ticagrelor | 50379-0011 | Powder | Bulk ingredients | April 29, 2014 |
| Etifoxine hydrochloride | 50379-0010 | Powder | Bulk ingredients | April 25, 2014 |
| Rivastigmine tartrate | 50379-0012 | Powder | Bulk ingredients | March 24, 2014 |
| Asenapine maleate | 50379-0009 | Powder | Bulk ingredients | July 3, 2012 |
| Pioglitazone hydrochloride | 50379-0008 | Powder | Bulk ingredients | July 3, 2012 |
| Topiramate | 50379-0007 | Powder | Bulk ingredients | June 21, 2012 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.